Clinical Trials Directory

Trials / Completed

CompletedNCT00004430

Randomized Study of Photodynamic Therapy Using Dihematoporphyrin in Patients With Corneal Neovascularization

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
150 (estimated)
Sponsor
Medical College of Hampton Roads · Academic / Other
Sex
All
Age
12 Years
Healthy volunteers
Not accepted

Summary

OBJECTIVES: I. Demonstrate the safety and efficacy of dihematoporphyrin derivative (DHP) in laser photodynamic therapy (PDT) in patients with corneal neovascularization. II. Document the histopathologic mechanism of action in selected patients undergoing penetrating keratoplasty following PDT therapy for corneal neovascularization. III. Facilitate FDA product approval of DHP as a photosensitizing agent for laser treatment in these patients. IV. Explore the use of this photosensitizer for ocular and cutaneous basal cell and squamous cell carcinoma.

Detailed description

PROTOCOL OUTLINE: This is a randomized, placebo controlled study. Patients are randomized to 1 of 3 treatment arms: Arm I: Patients receive topical dihematoporphyrin derivative (DHP) every 3 hours on days -3 and -2. Patients undergo laser surgery on day 0. After photodynamic (PDT) therapy, patients receive topical prednisolone phosphate four times a day for 90 days. Ninety days following PDT, patients may undergo corneal transplantation. Arm II: Patients receive placebo topical gel and undergo sham laser surgery following arm I schedule, then receive topical prednisolone phosphate four times a day for 90 days. Patients may be crossed over to arm I if disease progression is observed. Arm III: Patients receive a compressed 1 day schedule of DHP with 5 doses in the morning and then undergo laser surgery in the evening. Patients are assessed on days 1, 7, 30, and 90 after PDT therapy. Completion date provided represents the completion date of the grant per OOPD records

Conditions

Interventions

TypeNameDescription
DRUGDihematoporphyrin derivative
DRUGprednisolone
PROCEDURELaser surgery

Timeline

Start date
1994-09-01
Completion
1998-09-01
First posted
1999-10-19
Last updated
2015-03-25

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00004430. Inclusion in this directory is not an endorsement.